World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
33830
World Ranking
10836
National Ranking
387

Paolo Veronesi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paolo Veronesi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 466 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paolo Veronesi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paolo Veronesi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paolo Veronesi is affiliated with the European Institute of Oncology in Italy. Their research focuses primarily on cancer, with significant contributions in the treatment and understanding of breast cancer. They have an extensive publication record across several fields of study related to medicine, biochemistry, genetics, and molecular biology, with a notable emphasis on cancer research and surgery.

The main fields of study covered by Veronesi include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their work extends into several subfields such as:

  • Cancer Research
  • Surgery
  • Pathology and Forensic Medicine
  • Oncology
  • Pulmonary and Respiratory Medicine

Veronesi's research topics focus largely on breast cancer and related areas, including:

  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Breast Implant and Reconstruction
  • Cancer Risks and Factors
  • Cancer and Skin Lesions
  • BRCA gene mutations in cancer
  • Global Cancer Incidence and Screening

Prominent recent papers published by Veronesi include:

  • "Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes," 2023, JAMA Oncology
  • "Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial," 2021, The Lancet Oncology
  • "Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up," 2020, European Journal of Surgical Oncology
  • "E-cadherin deregulation in breast cancer," 2020, Journal of Cellular and Molecular Medicine
  • "Breast implant-associated anaplastic large cell lymphoma: A comprehensive review," 2020, Cancer Treatment Reviews

Veronesi frequently collaborates with a group of co-authors who have contributed to numerous publications alongside them. These co-authors include:

  • Viviana Galimberti
  • Giovanni Corso
  • Maria Cristina Leonardi
  • Francesca Magnoni
  • Vincenzo Bagnardi

The European Journal of Surgical Oncology is the venue where Veronesi has published the most, followed by other frequent publication venues such as:

  • European Journal of Surgical Oncology
  • Radiotherapy and Oncology
  • Annals of Surgical Oncology
  • Breast Cancer Research and Treatment
  • The Breast

Best Publications

  • A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Alberto Luini

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

    Umberto Veronesi;Giovanni Paganelli;Viviana Galimberti;Giuseppe Viale

  • Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

    Viviana Galimberti;Bernard F. Cole;Bernard F. Cole;Stefano Zurrida;Giuseppe Viale;Giuseppe Viale

  • Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.

    U Veronesi;G Paganelli;G Viale;V Galimberti

  • Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial

    U. Veronesi;E. Marubini;L. Mariani;V. Galimberti

  • Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial

    Umberto Veronesi;Roberto Orecchia;Roberto Orecchia;Patrick Maisonneuve;Giuseppe Viale;Giuseppe Viale

  • Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.

    Umberto Veronesi;Giuseppe Viale;Giovanni Paganelli;Stefano Zurrida

  • Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Giuseppe Viale;Alberto Luini;Alberto Luini

  • Very young women (<35 years) with operable breast cancer: features of disease at presentation

    M. Colleoni;N. Rotmensz;C. Robertson;L. Orlando

  • Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

    Viviana Galimberti;Bernard F Cole;Giuseppe Viale;Giuseppe Viale;Paolo Veronesi;Paolo Veronesi

  • Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors: A Study of Preoperative Treatment

    Marco Colleoni;Giuseppe Viale;David Zahrieh;Giancarlo Pruneri

  • Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?

    Virgilio Sacchini;José A. Pinotti;Alfredo C.S.D. Barros;Alberto Luini

  • Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer

    Giuseppe Curigliano;Giuseppe Viale;Vincenzo Bagnardi;Luca Fumagalli

  • Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial

    Bernardo Bonanni;Matteo Puntoni;Massimiliano Cazzaniga;Giancarlo Pruneri

  • Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer

    G. Cancello;P. Maisonneuve;N. Rotmensz;G. Viale;G. Viale

  • The oncologic outcome and immediate surgical complications of lipofilling in breast cancer patients: a multicenter study--Milan-Paris-Lyon experience of 646 lipofilling procedures.

    Jean Yves Petit;Visnu Lohsiriwat;Krishna B. Clough;Isabelle Sarfati

  • Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons

    Umberto Veronesi;Roberto Orecchia;Roberto Orecchia;Alberto Luini;Alberto Luini;Viviana Galimberti

  • Locoregional recurrence risk after lipofilling in breast cancer patients

    J.Y. Petit;E. Botteri;V. Lohsiriwat;M. Rietjens

  • Breast carcinoma in elderly women: Features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients

    Roberto Gennari;Giuseppe Curigliano;Nicole Rotmensz;Chris Robertson

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

    U. Veronesi;G. Paganelli;V. Galimberti;G. Viale

Frequent Co-Authors

Giuseppe Viale
Giuseppe Viale University of Milan
Viviana Galimberti
Viviana Galimberti European Institute of Oncology
Marco Colleoni
Marco Colleoni European Institute of Oncology
Umberto Veronesi
Umberto Veronesi European Institute of Oncology
Nicole Rotmensz
Nicole Rotmensz European Institute of Oncology
Vincenzo Bagnardi
Vincenzo Bagnardi University of Milano-Bicocca
Roberto Orecchia
Roberto Orecchia European Institute of Oncology
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
Aron Goldhirsch
Aron Goldhirsch European Institute of Oncology
Giancarlo Pruneri
Giancarlo Pruneri University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Medicine, there are several fast-growing career pathways beyond becoming a physician. Online learning has made health-related education more accessible than ever, with flexible programs that cater to busy schedules and reduce the financial burden. For those interested in the administrative side of healthcare, consider exploring online healthcare administration programs. These programs prepare graduates to manage hospitals, clinics, and other healthcare organizations.

Cost is often a top concern for prospective students. Researching masters in healthcare administration cost can help you find affordable options to further your career. Likewise, nursing professionals interested in leadership roles can benefit from cheapest online dnp programs, which offer a pathway to advanced clinical and executive roles.

Pharmacists also play a vital role in healthcare teams. If this career interests you, explore accredited online pharmacy programs that offer both flexibility and affordability. With these options, students can pursue a range of rewarding careers in medicine and healthcare without compromising on quality or breaking the bank.

Best Scientists Citing Paolo Veronesi

Trending Scientists

Recently Published Articles